**Question:** Ezetimibe acts on what?

**Core Concept:** Ezetimibe is a cholesterol-lowering medication that belongs to the class of drugs called statins and HMG-CoA reductase inhibitors. It is primarily used to lower high blood cholesterol levels, particularly LDL cholesterol, in patients with hypercholesterolemia or atherosclerosis.

**Why the Correct Answer is Right:** Ezetimibe selectively inhibits the absorption of cholesterol from the gastrointestinal tract by binding to and blocking the Niemann-Pick C1-Like 1 (NPC1L1) protein, which is an intestinal cholesterol transporter. By reducing the reabsorption of cholesterol, ezetimibe leads to a decrease in circulating cholesterol levels in the bloodstream.

**Why Each Wrong Option is Incorrect:**

A. Ezetimibe does not primarily act on the liver like statins or fibrates. It targets cholesterol absorption in the gut, not liver cholesterol synthesis.

B. Although statins inhibit HMG-CoA reductase, ezetimibe works independently of this pathway.

C. Ezetimibe does not target the HMG-CoA reductase enzyme, which is the primary action of statins, but rather inhibits cholesterol absorption.

D. Unlike fibrates, which primarily act on beta-oxidation of fatty acids, ezetimibe works through a different mechanism, focusing on cholesterol absorption.

**Clinical Pearl:** By focusing on cholesterol absorption, ezetimibe provides an alternative approach to managing hyperlipidemia and reducing cardiovascular risk alongside lifestyle modifications and other lipid-lowering therapies. Ezetimibe is typically prescribed in combination with statins to further enhance cholesterol-lowering effects and improve cardiovascular outcomes in patients with established cardiovascular disease or high risk for atherosclerosis.